Peptides for Sleep

Last reviewed 2026-08-25

The honest answer first

DSIP is essentially the only peptide marketed specifically for sleep, and its evidence base is thin, dated and largely unreplicated. It is not FDA-approved, and we have found no approved sleep indication for it in the United States. For most people with a sleep problem, cognitive behavioural therapy for insomnia has far better evidence than anything on this page.

Delta sleep-inducing peptide was first described in 1977, isolated from the cerebral venous blood of rabbits during induced sleep — an origin that captures both why it is interesting and how old the underlying work is.

Most of the human research dates from the 1980s and 1990s and has not been meaningfully replicated since. Growth hormone secretagogues are also sometimes reported to improve sleep quality, which is a secondary effect rather than their purpose.

What gets used for sleep, and what backs it

Every entry carries the level of human evidence for this use — not the compound’s approval status for something else.

Sleep peptides compared by evidence, FDA status and typical monthly cost
PeptideEvidence for this goalFDA statusTypical cost/mo
DSIPLimited human dataResearchNot published

What has the strongest support

Nothing here has good modern evidence. Cognitive behavioural therapy for insomnia has substantially better support than any peptide sold for sleep.

Medical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.

Frequently Asked Questions

The evidence is limited, mostly from small studies in the 1980s and 1990s, and has not been meaningfully replicated. It is not FDA-approved.

Find a provider

Our directory lists clinics whose own websites show they offer peptide therapy. We verify what each one actually provides rather than taking a listing at face value.

Browse the provider directory

Related goals